Founded in 2010, Empirical Bioscience, a Fortis Life Sciences brand, develops molecular biology reagents and specialty enzymes. The company supports research, diagnostic development and commercial assay manufacturing. It specialises in recombinant protein production, enzyme engineering and assay formulation. Its products support PCR, qPCR, RT-PCR, SNP genotyping, next-generation sequencing and CRISPR workflows. They also offer custom assay development, contract manufacturing and reagent development services. These services support molecular diagnostics and life science research applications.
Empirical Bioscience offers proprietary enzymes, recombinant proteins, molecular biology buffers and PCR/qPCR master mixes. The InhibiTaq™ qPCR MasterMix range supports reliable nucleic acid amplification and assay performance. The company also develops custom enzymes, private-label assay kits and tailored reagent formulations. Its products support diagnostic and research applications. Researchers use its technologies in genomics, infectious disease research and molecular diagnostics. The portfolio also supports assay development and molecular testing workflows. These tools help generate dependable results from sample preparation through detection.
Europa Biosite’s subsidiaries distribute for Empirical Bioscience in Belgium, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden and the United Kingdom.
